Calidi Biotherapeutics, Inc. CLDI
Set alert
0.69 USD +0.03 +4.86%
As of Nov 3, 2:12 PM ET
0.6298 Day range 0.69
0.62 52-week range 27.04
- YTD
- -96.31%
- 1 year
- -97.18%
- Open
- 0.6298
- Prev close
- 0.658
- Mkt cap
- 2.54M
- Vol
- 36.90K
- Avg vol
- 131.16K
- EPS
- -36.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6298
- High
- 0.69
- Forward P/E
- -1.57
- Beta
- 0.57
- Short ratio
- 0.88
- Inst. own
- 2.71%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.67
- 200-d avg
- 2.22
- 1y target
- 6.25
Analyst view
Price target (mean) 6.25 +805.8% upside
Now 0.69
- Target (low)
- 2.50
- Target (mean)
- 6.25
- Target (high)
- 10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 27, 2024 | Ladenburg Thalmann | Initiated | — | Buy |
| May 15, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 21, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 22, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 9, 2023 | Baird | Initiated | — | Outperform |